Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

Fig. 3

Orexin A significantly reduces inflammatory responses in the CNS. The panel shows the mRNA expression of chemokines (i.e., MCP-1 or CCL2 and IP-10 or CXCL10), cytokines (i.e., TNF-Ī±, IL-10, IFN-Ī³ (Th1), IL-17 (Th17), IL-4 (Th2), and TGF-Ī²) and the transcription factor, Foxp3 (Treg-specific) determined by real time RT-PCR in naĆÆve animals and EAE mice (i.e., 15 and 21Ā days after EAE induction in PBS- and OxA-treated mice, nā€‰=ā€‰6/group and nā€‰=ā€‰7/group respectively). *Pā€‰<ā€‰0.05 (Mann-Whitney test, compared to PBS group)

Back to article page